Regen Biopharma's market cap is currently $831.38K. The company's EPS TTM is $-0.088; its P/E ratio is ―; Regen Biopharma is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Sep 22	Sep 21	Sep 20	Sep 19
Income Statement
Total Revenue	$ 236.56K	$ 235.52K	$ 171.19K	$ 110.00K	$ 110.00K
Gross Profit	$ 236.56K	$ 185.52K	$ 146.19K	$ 110.00K	$ 110.00K
Operating Income	$ -686.95K	$ -339.61K	$ -200.77K	$ -209.32K	$ -756.78K
EBITDA	$ 1.22M	$ 2.99M	$ -6.40M	$ 4.36M	$ -753.75K
Net Income	$ 1.02M	$ 5.49M	$ -7.13M	$ 1.79M	$ -4.32M
Balance Sheet
Cash & Short-Term Investments	$ 121.04K	$ 51.20K	$ 727.16K	$ 0.00	$ 7.86K
Total Assets	$ 353.62K	$ 559.00K	$ 1.21M	$ 123.19K	$ 99.09K
Total Debt	$ 756.20K	$ 1.27M	$ 3.58M	$ 2.60M	$ 2.15M
Net Debt	$ 635.17K	$ 1.22M	$ 2.86M	$ 2.60M	$ 2.14M
Total Liabilities	$ 5.46M	$ 8.60M	$ 14.70M	$ 7.46M	$ 11.01M
Stockholders' Equity	$ -5.10M	$ -8.04M	$ -13.49M	$ -7.33M	$ -10.91M
Cash Flow
Free Cash Flow	$ -173.92K	$ -606.92K	$ -1.13M	$ 18.64K	$ -481.79K
Operating Cash Flow	$ -173.92K	$ -606.92K	$ -1.13M	$ 18.64K	$ -481.79K
Investing Cash Flow	$ 0.00	$ 25.00K	$ 495.00K	$ 0.00	$ 49.86K
Financing Cash Flow	$ 243.75K	$ -94.04K	$ 1.36M	$ -26.50K	$ 431.77K

Currency in USD

Regen Biopharma Earnings and Revenue History

Income Statement >

Regen Biopharma Debt to Assets

Balance Sheet >

Regen Biopharma Cash Flow

Cash Flow >

Regen Biopharma Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing